Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ferrlecit Maintenance Therapy in Hemodialysis Patients
NCT00223938Phase 4Terminated
- Sponsor
- Sanofi
- Start
- Dec 2003
- Primary completion
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sodium ferric gluconate in anemia (3 arms), sponsored by Sanofi. Primary endpoint: Efficacy of Ferrlecit vs Oral Iron in Maintenance of Iron Stores and Serum Hemoglobin at 22 weeks. Started Dec 2003; status: terminated.
02
Drugs
sodium ferric gluconate
03
Conditions
anemia
Beyond the preview
Go deeper on NCT00223938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223938.